Vaccine-Associated Paralytic Poliomyelitis in the Postelimination Era in Latin America and the Caribbean, 1992–2011
Open Access
- 11 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 209 (9), 1393-1402
- https://doi.org/10.1093/infdis/jit602
Abstract
The Americas interrupted the transmission of poliovirus in 1991; most Latin American and Caribbean (LAC) countries rely on the oral polio vaccine (OPV) to maintain elimination. We estimated the risk of vaccine-associated paralytic polio (VAPP) in LAC for 1992–2011. VAPP cases were identified using LAC's acute flaccid paralysis (AFP) surveillance system. VAPP was defined as any AFP case with residual paralysis 60 days following onset that did not have a clear alternative etiology and with isolation of vaccine-strain poliovirus. Recipient VAPP cases were defined as those with paralysis onset 4–40 days following OPV; cases meeting these criteria but with unknown residual paralysis were added. Nonrecipient VAPP cases were defined as those in individuals with an unknown vaccination status, those in individuals who received 0 doses, or those with paralysis onset outside the 4–40-day interval. Of 40 926 AFP cases reported in LAC from 1992–2011, we identified 72 recipient and 119 nonrecipient VAPP cases. The estimated risk of recipient VAPP was 1 case per 3.15 million newborns (95% confidence interval [CI], 1 case per 2.56–4.10 million newborns), and the estimated overall risk was 1 case per 1.19 million newborns (95% CI, 1 case per 1.04–1.39 million newborns). In this multicountry VAPP analysis in a postelimination period, we found that the risk of VAPP in LAC was lower than previously estimated.Keywords
This publication has 14 references indexed in Scilit:
- Switching from OPV to IPV: are we behind the schedule in Latin America?Expert Review of Vaccines, 2010
- Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en ColombiaRevista Panamericana de Salud Pública, 2010
- Guillain‐Barré Syndrome in Children Aged <15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) PandemicThe Journal of Infectious Diseases, 2010
- OPV Cessation--the Final Step To a "Polio-Free" WorldScience, 2005
- Ocorrência de poliomielite associada à vacina no Brasil, 1995 a 2001Revista Panamericana de Salud Pública, 2005
- Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United StatesJAMA, 2004
- Paralytic poliomyelitis in England and Wales, 1985-91.BMJ, 1992
- Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated DiseaseClinical Infectious Diseases, 1992
- A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.American Journal of Public Health, 1989
- Vaccine-Associated Paralytic PoliomyelitisJAMA, 1987